Nuclear factor-kappaB in cancer development and progression
about
Maternal undernutrition and cardiometabolic disease: a Latin American perspectiveMaslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathwayTumor promoting or tumor suppressing of NF-kB, a matter of cell context dependencyDDRGK1 regulates NF-κB activity by modulating IκBα stabilityBrd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelASHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complexTWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-κB signalingEmerging roles for the non-canonical IKKs in cancerInflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activationInactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activationThe IkappaB kinase complex: master regulator of NF-kappaB signalingThe RNA aptamer disrupts protein-protein interaction between beta-catenin and nuclear factor-kappaB p50 and regulates the expression of C-reactive proteinInvolvement of linear polyubiquitylation of NEMO in NF-kappaB activationPar-4 inhibits Akt and suppresses Ras-induced lung tumorigenesisStabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasionTCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathwayPellino3 targets RIP1 and regulates the pro-apoptotic effects of TNF-αHDAC inhibitors as anti-inflammatory agentsIs NF-kappaB a good target for cancer therapy? Hopes and pitfallsmiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in miceZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell linesNeural sensitivity to social rejection is associated with inflammatory responses to social stressMicroRNAs in NF-kappaB signalingBLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug developmentDelta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signal-regulated kinase/mammalian target of rapamycin signalingAnnexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivoActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesLoss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesisPathogen recognition and inflammatory signaling in innate immune defensesmiRGen 2.0: a database of microRNA genomic information and regulationThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodiesMechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytesInduction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signalsCancer immunoediting from immune surveillance to immune escapeMolecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemopreventionTargeting protein serine/threonine phosphatases for drug developmentAutophagy and NF-kappaB: fight for fatePancreatic cancer: pathogenesis, prevention and treatmentMicroRNA-155 is induced during the macrophage inflammatory response
P2860
Q21146681-D9075A78-47C4-4422-A924-8DD91B1AD166Q21245702-16BBE2DA-92C3-4CC5-952D-C90866064530Q23912835-5FB7B9B5-C25B-4199-8B0C-C76E94D37800Q24292872-47818102-47E5-490A-A2A1-ADD7A5532044Q24293271-E404B799-03E3-4CE4-9A02-281225814D1FQ24298605-D5E54D73-9C7A-44B5-B4B1-7EB0B7D7B15BQ24300508-3E7A0C31-E5B7-4334-8E06-5D33EE94917CQ24301538-28999755-DDCE-4B7C-B6B2-66232833FF78Q24305225-C55FC4C0-0E25-46A8-B751-229B91351FDDQ24309469-22CF1735-DF25-4D8A-B0BE-1415412D21F8Q24311308-8A8E2EBD-DF64-4D5A-8243-EB2A58B3C125Q24313366-129F27AB-55A5-403C-931A-BCF39636E073Q24314511-AAB78192-EEA3-49FA-9B6A-4C64A8B65CB6Q24315943-D963C3AC-7F02-4473-84F5-3DE47695E1DAQ24316409-2ADA740B-FB7C-4169-8127-4E3612B9082FQ24321517-6720C000-864E-4E5F-A424-EC31B809C1C0Q24336598-5E3B3349-8AB9-4D38-93A7-FEFBA821ED15Q24338172-C845E278-1D50-4C74-825F-6F16D84D1FC3Q24564962-AF3C197A-409B-4020-95AC-EDD8E6BB3FA8Q24570128-F74E20FD-1CEC-4A7D-8E99-F4CC16B31BBBQ24595073-10ECA0E3-D5E7-4D35-84ED-53E3FA13D262Q24600930-1A1BE769-1576-4789-BC7D-388D253781A5Q24622084-60161399-3DEF-4E86-A32A-5DAC87EB7B87Q24630097-A11B0BA5-5687-4257-BDA7-F152155D99A9Q24631264-520416FC-E87C-4BA2-A52D-F2D0CE8FCED5Q24632362-EA737B10-6A46-47E6-A6AA-C004F7694EF4Q24632505-071416BF-86F0-4920-8861-C70B48782856Q24632768-FB57ABF5-3EB1-4561-8C54-08246B432B68Q24633009-BA6ABA22-A0F4-4C62-9CB2-7B97A72A0BF9Q24643034-66353CBC-5E48-4432-9F5E-86C45D5802FBQ24644535-6477C984-CF8A-471E-936B-0A0D1C37E3C7Q24646616-2CCE89B7-CF55-401A-ADDE-3C9D971B0E8BQ24648789-C3534F03-44BE-40A0-B63A-A983C7C64601Q24649064-BF328E54-DC0D-482E-B79C-5B91602CE751Q24655415-906EF78E-D302-41BB-816B-1D25D3D8288CQ24657569-D5F50721-177C-430F-907F-AA57C9E46F90Q24658001-99F5A797-AB54-4008-8DB9-458E7F789CFEQ24658157-B3EE913D-8A18-4145-AFB7-4634E59243C0Q24670990-6D143C9C-F61A-491D-B349-9CC279FB286EQ24683841-9EDA2CE8-1B5F-493B-8372-0C5F75943745
P2860
Nuclear factor-kappaB in cancer development and progression
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Nuclear factor-kappaB in cancer development and progression
@ast
Nuclear factor-kappaB in cancer development and progression
@en
type
label
Nuclear factor-kappaB in cancer development and progression
@ast
Nuclear factor-kappaB in cancer development and progression
@en
prefLabel
Nuclear factor-kappaB in cancer development and progression
@ast
Nuclear factor-kappaB in cancer development and progression
@en
P3181
P356
P1433
P1476
Nuclear factor-kappaB in cancer development and progression
@en
P2093
P2888
P3181
P356
10.1038/NATURE04870
P407
P577
2006-05-25T00:00:00Z
P5875
P6179
1043364117